52
Growth Score in past quarter
pts
Heat Score 52 in past quarter
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1008219
BioGenes offers custom antibody and immunoassay development and services.
- Sergej Ovodov: Co-Founder and Scientific Director
- Alexander Knoll: Founder and CEO
About the Company
BioGenes GmbH, founded in 1992, is a world-wide acting full-service provider for customised immunoassay and antibody development with strong commitment to quality and service.
Their scientists possess an unrivaled expertise in ELISA development, validation and production for biotech, pharma, medical device and clinical diagnostic applications.
Their extensive antibody know-how allows for complex antibody development.
BioGenes is certified to meet the international requirements and regularities of quality assurance and animal welfare and maintains long-term alliances with biotech and pharmaceutical companies as well as research institutes all over the world.